PROCEPT BioRobotics Corporation (PRCT)

Every figure this model derived for PRCT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 10,585,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 227,914,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 420,285,000 AssetsCurrent 2026-06-30
current liabilities 64,196,000 LiabilitiesCurrent 2026-06-30
equity 340,070,000 StockholdersEquity 2026-06-30
interest expense 3,473,000 InterestExpenseNonoperating 2026-06-30
ocf -74,340,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 337,340,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 52,938,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up PRCT on one particular measure came for.

RatioValue
cash operating margin-16.08
current ratio8.39
current ratio reported6.55
deferred revenue growth42.46
dilution pct6.56
fcf margin-25.17
growth cv0.86
interest cover-32.89
operating margin-33.86
owner earnings margin-40.87
revenue growth22.69
revenue growth per share15.13
roic-55.07
rule of 40-11.17
sbc pct revenue15.69

What to be careful about

What this model itself distrusts about PRCT's figures. Written by the derivation as it ran, not added afterwards.